"If this works the way we think it's going to work, it will change medical practice."

Cameron Ramsden By Cameron Ramsden

I spoke with Bob Proulx, Chairman and CEO of Imagion Biosystems. 

Imagion are blazing a trail in the world of imaging with their fascinating technology, which utilises nanoparticles to help detect cancer with better specificity and sensitivity, without exposure to radiation.

In our conversation, we covered the technology, what it's like to be classed as an FDA 'breakthrough' device and what the future holds for Imagion and the imaging market in general. 

If you'd like to see more content like this, please visit my consultant page. You can also get in touch with me to talk about the podcast at Cameron.Ramsden@medical-cm.com.

If you'd like to get involved in the conversation, email us at cmconversations@charltonmorris.com.


Get the latest into your inbox.